Stay Informed About Key Developments for Our Company

The Latest Updates as They Happen

As a valued partner in our shared success, you should be the first to know what’s happening across our company. The articles and announcements below offer a comprehensive glimpse into the recent developments that shape our business and growth strategies.

 

News
51 - 60of about 655 News
51 - 60of about 655 News
February 08, 2021
Not intended for U.S. and UK Media
New data presented at 2021 ASCO GU Cancers Symposium add to robustness of the overall survival benefit and favorable safety profile for Nubeqa™
READ MORE
February 08, 2021
Not intended for U.S. and UK Media
Bayer and Orion expand development program for darolutamide in prostate cancer
READ MORE
February 03, 2021
Bayer announces agreement with plaintiffs’ counsel on class plan
READ MORE
February 03, 2021
Not intended for U.S. and UK Media
Bayer receives approval for Nubeqa™ in China for the treatment of men with non-metastatic castration-resistant prostate cancer (nmCRPC)
READ MORE
January 20, 2021
Not intended for U.S. and UK Media
U.S. FDA approves vericiguat for patients with symptomatic chronic heart failure
READ MORE
January 13, 2021
Not intended for U.S. and UK Media - Virtual Bayer Pharma Media Day:
Bayer transforms pharma business through breakthrough innovation in healthcare
READ MORE
January 12, 2021
Not intended for U.S. and UK Media
U.S. FDA grants Priority Review to New Drug Application for finerenone to treat patients with chronic kidney disease and type 2 diabetes
READ MORE
January 11, 2021
Accelerating the Transformation of Bayer:
Supervisory Board of Bayer AG appoints Sarena Lin to Board of Management as Chief Transformation and Talent Officer
READ MORE
January 07, 2021
NOT FOR DISTRIBUTION IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, SOUTH AFRICA OR JAPAN
Bayer issues new senior bonds with a volume of 4 billion euros
READ MORE
January 07, 2021
CureVac and Bayer join forces on COVID-19 vaccine candidate CVnCoV
READ MORE
51 - 60of about 655 News
51 - 60of about 655 News

 

Subscribe To Our Investor News Email Alerts

Ad-Hoc Releases

Discover Bayer's Latest Ad-Hoc Releases

read more